DreamersVC
Dreamers VC is a venture capital firm based in Los Angeles, California, founded in 2018 by Will Smith and Keisuke Honda. The firm connects U.S. tech founders with Japanese and Asian partners, leveraging a global network to accelerate mainstream awareness and draw corporate investors like Shiseido and Asics. The team consists of four professionals who focus on supporting high-growth markets.
Dreamers VC invests in sectors such as technology, consumer products, enterprise, entertainment, fintech, health, and biotechnology. They typically write checks ranging from $500k to $5 million, focusing on Seed to Series B stages. The firm primarily invests in the USA and aims to create more efficient and inclusive futures through its portfolio companies.
Notable investments by Dreamers VC include Alchemy - blockchain technology, Bolt - streamlined checkout solutions, The Boring Company - urban tunnel solutions, Tonal - personalized workout equipment, Oura - health tracking rings, Pangaia - sustainable materials, and Our Place - modern kitchenware.
DreamIt Ventures
Dreamit Ventures invests in transformative early-stage cybersecurity startups with revenue or pilots that are ready to scale. Our deep expertise and extensive network of partners ignite revenue growth and open doors to smart capital. Since its founding in 2008, Dreamit has invested in 300+ companies across four funds, including Oort (acquired by Cisco), LevelUp (acquired by GrubHub), Trendkite (acquired by Cision), SeatGeek, HouseParty (acquired by Epic Games), Adaptly (acquired by Accenture), Wellth, Biomeme, Tissue Analytics (acquired by Net Health), Redox, Eko Devices, NestEgg, Cylera and Elevate.
Dreampact Ventures
Dreampact Ventures is a venture capital firm based in New York, New York, founded in 2018. The firm is led by a team with global executive experience across various disciplines, including strategy, sales, finance, and technology. Dreampact Ventures distinguishes itself by offering not only financial resources but also mentorship and strategic guidance, aiming to be deeply involved with the companies they invest in.
The firm focuses on early-stage investments, primarily targeting Seed to Series A rounds. Dreampact Ventures invests in sectors such as fintech, edtech, entertainment, longevity and wellness, and consumer technology. They typically seek to acquire a 10% equity stake or a clear path to such a position. The firm operates globally, leveraging its extensive network to support ambitious founders in major markets.
Notable investments by Dreampact Ventures include Plexuss - a digital network platform, Become - a business financial solutions provider, Ryvit - business productivity software, and Balance the Superfood Shot - a beverage company. The firm is committed to fostering long-term partnerships with its portfolio companies, providing the necessary support to help them grow and succeed.
DreamX
DreamX is a Sports Accelerator from the house of Dream Sports, with brands such as Dream11, FanCode, DreamSetGo and DreamPay in its portfolio. Started in July 2019, DreamX provides an all-round sports tech startup program that includes investment, mentorship and valuable support across categories.
With a deep passion for sports and a sincere quest to create endless possibilities for every sports consumer in the country; DreamX was born to transform this into a reality. By being a business builder and supporting sports entrepreneurship, to cultivate multiple game-changing sports startups in India.
Dresselhaus Ventures
Dresselhaus Ventures is a family office with a venture focus, based in Berlin, Germany. The firm traces its roots back to the 1950s in Germany and has a strong digital DNA. The team is small, consisting of 1-10 employees, and is known for its entrepreneurial heritage and commitment to challenging the status quo.
Dresselhaus Ventures invests in a variety of sectors including business services, fashion, and consumer products, with a particular focus on Europe and Germany. The firm does not specify check sizes or stages but is involved in venture capital activities. They have not disclosed specific funds or total assets under management.
Notable investments by Dresselhaus Ventures include companies in the digital and consumer sectors, although specific portfolio companies are not detailed in the available sources.
DRI Capital
DRI Capital is a private equity firm based in Toronto, founded in 1992. The firm specializes in investments in the pharmaceutical and healthcare sectors, focusing on acquiring dependable, patent-protected cash flow streams derived from the sales of important drugs. The team is characterized by its expertise in pharmaceutical royalty monetization and is known for its creative and flexible investment structures. DRI Capital's dedication to addressing unmet medical needs differentiates them in the industry.
DRI Capital invests primarily in the healthcare sector, with a particular emphasis on royalty streams from medically necessary products with long-term patent protection. They target investments in North America, Europe, and other regions with a focus on pharmaceuticals. While the exact check sizes are not publicly detailed, their strategic focus implies substantial investments in their target markets. The firm has a diversified portfolio, including interests in notable drugs such as Synagis, Remicade, and Keytruda.
Their portfolio boasts a wide range of investments in leading pharmaceutical products. Notable investments include Synagis, Remicade, Myozyme, Enbrel, and Soliris, showcasing DRI Capital's strategic focus on products with high growth potential and significant medical impact. The firm's approach in acquiring royalty streams has allowed them to build an extensive and varied portfolio, which underscores their commitment to value creation in the healthcare industry.
Drive Capital
Drive Capital is a venture capital firm based in Columbus, Ohio, founded in 2012 by Chris Olsen and Mark Kvamme, both former partners at Sequoia Capital. The firm is composed of a team of 16 partners and focuses on investing in the Midwest region of the United States. Drive Capital distinguishes itself by partnering with entrepreneurs who are building world-class technology companies outside the traditional tech hubs.
The firm invests in a variety of sectors including healthcare, fintech, AI, robotics, and enterprise software. Drive Capital typically invests in Seed to Series B+ stages, with check sizes ranging from $5 million to $30 million. The firm manages approximately $2 billion in assets under management and has a portfolio of 87 companies.
Notable investments by Drive Capital include Duolingo - language learning platform, Notion - productivity software, KOHO - financial services, SonderMind - mental health services, and CirrusMD - telemedicine platform. These investments highlight Drive Capital's commitment to supporting innovative companies across diverse industries.
Driventure
Driventure is an investor with no available direct website content, making it difficult to gather detailed information about their operations, team, and focus. Unfortunately, there's no data regarding their headquarters, founding year, founders, or team composition. Given the absence of a dedicated web presence, they might operate under a different web domain or predominantly through offline networks.
Due to the lack of information from a business website or announcement article, details like sector focus, investment stages, check sizes, geographic focus, and total assets under management remain unknown. Similarly, there is no available data on their limited partners or strategic partners.
With no publicly visible portfolio companies or records available, it's impossible to currently highlight any notable investments made by Driventure. As such, anyone seeking details might need to explore alternative sources like financial databases or news announcements.
Droia Oncology Ventures
Droia Oncology Ventures is an investment firm specializing in life sciences, notably in oncology and genetic disease. Based in Belgium, Droia is led by a team of drug development experts and biotech professionals who actively support companies from creation through clinical proof of concept. What sets them apart is their hands-on approach, taking interim roles within portfolio companies to help them progress more swiftly.
The firm invests globally in young drug development companies with innovative approaches to address unmet medical needs. Droia targets sectors such as pharmaceuticals, biotechnology, and the broader life sciences space, focusing on companies capable of clinical breakthroughs. Their stage preference includes early-stage, Series A, and venture formation, with an investment range of $10-50 m. Specific fund sizes and strategic partners are not disclosed.
Notable investments by Droia include Accent Therapeutics - developing therapies in epitranscriptomics, Arcus Biosciences - focusing on immune-oncology combinations, and Frontier Medicines - leveraging chemoproteomics for drug development. Additional portfolio companies include Actio Biosciences, Alesta Therapeutics, Cyteir Therapeutics, and several others, indicating their broad reach within oncology and genetic disease therapeutics.
Drum Capital Management
Drum Capital Management is a private equity firm based in North America, established in 2004 by Scott Vollmer, a veteran with over 30 years in the industry. The firm specializes in deep value, turnaround, and special situation investing in the lower middle markets. They are noted for their operational and financial expertise, leveraging extensive industry relationships to provide diversified and unsyndicated exposure through primary fund investments, co-investments, and direct investments. The team at Drum Capital has over 100 years of combined experience and is dedicated to generating differentiated returns across various economic cycles.
Drum Capital targets deep value investment opportunities, focusing on turnarounds, special situations, value buyouts, restructurings, and operationally complex or distressed situations. They manage more than $1.4 billion across four series of funds. Their investments are primarily located in North America, and they collaborate closely with general partners to access primary fund investments and attractive direct and co-investment deals.
Notable portfolio companies include investments across various industries, although specific company names are not provided on the site. Drum's strategic approach and focus on capital structure and asset value allow them to adapt and thrive through economic cycles, making them a credible player in the private equity market.